stockrow
Friday 6 November 2026
Export BMRA’s income statement to Excel — free account
Biomerica, Inc.
BMRA Healthcare Medical Devices
Biomerica, Inc.’s revenue for fiscal 2026 (year ended May 2026) was $4.5 million, down 16.2% from fiscal 2025.
- Revenue
- −8.33%
- EPS
- −46,350.0%
- Free cash flow
- −199.3%
Quarter to August 2026, against a year earlier
1.61
0.00
0.00%
Follow BMRA
Alert me
Biomerica, Inc. (BMRA) P/E ratio
Biomerica, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 0.0× | — |
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Aug 2026 | 0.0× | — |
| May 2026 | 0.0× | — |
| Feb 2026 | 0.0× | — |
| Nov 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BTCY Biotricity Inc. compare | n/m |
| INBS Intelligent Bio Solutions Inc. compare | n/m |
| BDMD Baird Medical Investment Holdings Limited compare | n/m |
| NMTC NeuroOne Medical Technologies Corporation compare | n/m |
| VNRX VolitionRX Limited compare | n/m |
| TBIO Telesis Bio Inc. compare | n/m |
| AEMD Aethlon Medical, Inc. compare | n/m |
| BMRA Biomerica, Inc. | n/m |
| NVNO enVVeno Medical Corporation compare | n/m |
| Medical Devices industry median | 24.9× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)